• Journal of Chest Surgery
• /
• v.33 no.6
• /
• pp.476-486
• /
• 2000

Background: Pulmonary atresia with intact ventricular septum(PA/IVS) is an anatomically heterogenous anomaly with a variety of surgical strategies possible. The purpose of the study is to evaluate the influence of right ventricular size on the early and midterm results of surgical repair of PA/IVS. Material and method: Medical records of 20 consecutive patients with PA/IVS operated on between January 1993 and August 1999 were retrospectively reviewed. There were 12 boys and 8 girls whose ages ranged from 2 days to 14.5 months (median 6 days). Their body weight ranged from 2.52kg to 9.35 kg(median 3.18kg). The preoperative Z-value of the diameter of the tricuspid valve(T-valve) was less than or -4 in 5 patients, between -4 and -2 in 1, between -2 and 0 in 7, between 0 and 2 in 6, and greater than or 2 in 1. All patients who had z-value of tricuspid valve greater than -2.05 were attempted biventricular repair(n=15) and all patients who had it smaller than -4.4 underwent systemic-pulmonary shunt operation only(n=3) or bidirectinal cavopulmonary shunt with right ventricular reconstruction(n=2). Result: Two early deaths(2/20, 10%) occurred. Both were infants who underwent transannular patch with shunt. One of these two had huge right ventricle(Z-value of tricuspid valve = 5). There were 2 late non-cardiac deaths 3 and 7 months after operations respectively. Follow-up was completed in all children at a mean of 35.3 months(range, 5 to 54 months). 10 of 11 survivors who underwent transannular patch or valvotomy with or without shunt procedure were in NYHA functional class I even though some of them had small interatrial communication or patent shunt. All three patients who had shunt procedure only at initial palliation completed Fontan procedures with no death. Two patients who underwent right ventricular outflow reconstruction with bidirectional cavopulmonary shunt were also in good condition. Conclusion: The transanular RVOT patch or valvotomy with or without systemic-pumonary shunt as an initial palliative procedure to achieve biventricular repair for the patients who had neither too small nor too large right ventricle(-2.05$\leq$Z-value of T-value of T-valve$\leq$2) could be performed at low operative risk(1/14 7.1%). Systemic-pulmonary shunt procedure and bidirectional cavopulmonary shunt procedure for the patients who had small right ventricle(Z-value of T-valve$\leq$4.4) could be also performed with low risk. But a patient with huge right atrium and ventricle(Z-value of t-valve=5) had poor operative result.

• Proceedings of the Korean Society of Tribologists and Lubrication Engineers Conference
• /
• 2002.10b
• /
• pp.241-242
• /
• 2002

Wear behavior or SiC-particle reinforced aluminum matrix composites (MMC) were investigated by pin-on-disk tests in vacuum with various pressures, argon, and air with various levels of humidity. The wear rate of 2024Al and MMC increased in the following order: in a vacuum at $5.0{\times}10^{-4}$ Pa, at 1.0Pa, in argon at 0% RH, in argon at 60% RH, in argon at 90% RH, in air at 0% RH, in air at 60% RH and in air at 90% RH. In other words, the influence or environment on wear becomes stronger in the following order: moisture, oxygen, and a combination of moisture and oxygen. In various environments, the difference of the wear rate of 2024Al and MMC was compared. In argon and air at 0% RH, the wear rates of MMC were higher than that of 2024Al. In contrast, in argon and air at 60, 90% RH, the wear rates of MMC were lower than that of 2024Al.

• Journal of the Korean Ceramic Society
• /
• v.32 no.3
• /
• pp.385-393
• /
• 1995

Akali-resistant porous glass was prepared by phase separation in Na2O-B2O3-SiO2 system containing ZrO2 and MgO. ZrO2 was added for alkali-resistance and MgO for anti-cracking during leaching. Optimal content of ZrO2 for alkali-resistance was 7wt% and devitrification by heat treatment resulted from further addition. Pore size and pore volume were decreased and specific surface area was increased with ZrO2 addition due to depression in phase separation. Addition of 3mol% MgO to mother glass containing 7wt% ZrO2 was effective for anti-crack during leaching. In this case, with phase separation at 55$0^{\circ}C$ and 5$25^{\circ}C$ for 20 hrs. crack-free porous glasses could be prepared. The relation between pore size r and heat treatment time t at 55$0^{\circ}C$ was D=25.58＋18.16t. According to measurement of gas permeability, the mechanism of gas permeation was Knudsen flow. N2 and He permeability of porous glass which was prepared by heat treatment at 55$0^{\circ}C$ for 20 hrs. were 0.843$\times$10-7mol/$m^2$.s.Pa and 2.161$\times$10-7mol/$m^2$.s.Pa respectively.

• Transactions of the Korean Society of Mechanical Engineers A
• /
• v.22 no.2
• /
• pp.416-427
• /
• 1998

Unidirectional commingled-yarn-based carbon fiber(CF)/polyamide(PA) 6 composite was fabricated under molding pressures of 0.4, 0.6 and 1.0 MPa to study its flexural deformation and fracture behavior. Fiber/matrix interfacial bonding area became larger with an increase of molding pressure from 0.4 to 0.6 MPa. For molding pressures .geq. 0.6 MPa, good flexural performance of similar magnitudes was attained. For the fracture test, four kinds of notch direction were adopted : edgewise notches parallel (L) and transverse (T) to the major direction of fiber bundles, and flatwise notches parallel(ZL) and perpendicular(ZT) to this direction. Nominal bend strength for L and ZL specimens exhibited high sensitivity to notching. ZL specimens revealed the lowest values of the critical stress intensity factor $K_c$ which was slightly superior to those of unfilled PA6 matrix. Enlargement of the compression area for T specimens was analyzed by means of the rigidity reduction resulting from the fracture occurrence.

• BMB Reports
• /
• v.46 no.10
• /
• pp.484-489
• /
• 2013

Piperlonguminine (PL), an important component of Piper longum fruits, is known to exhibit anti-hyperlipidemic, antiplatelet and anti-melanogenic activities. Here, the anticoagulant activities of PL were examined by monitoring activated-partial-thromboplastin-time (aPTT), prothrombin-time (PT), and the activities of thrombin and activated factor X (FXa). The effects of PL on the expressions of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) were also tested in tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) activated HUVECs. The results showed that PL prolonged aPTT and PT significantly and inhibited the activities of thrombin and FXa. PL inhibited the generation of thrombin and FXa in HUVECs. In accordance with these anticoagulant activities, PL prolonged in vivo bleeding time and inhibited TNF-${\alpha}$ induced PAI-1 production. Furthermore, PAI-1/t-PA ratio was significantly decreased by PL. Collectively, our results suggest that PL possesses antithrombotic activities and that the current study could provide bases for the development of new anticoagulant agents.

• Journal of Veterinary Clinics
• /
• v.34 no.4
• /
• pp.275-278
• /
• 2017

An 8-year old female Korean Short Hair cat with a history of paralysis of both hind limbs less than 1 hour before admission was referred. On physical examination, the left hind limb was cold and there was no pulsation or mobility. On abdominal ultrasound examination, a thrombus 8 mm in length was found at the aortic bifurcation. The patient was diagnosed with hypertrophic cardiomyopathy (HCM) and cardiogenic pulmonary edema through radiologic evaluation and echocardiography. A tissue plasminogen activator (tPA) was applied intravenously using an accelerated dosing protocol (1 mg administered intravenously [IV] bolus, 2.5 mg IV over 30 min, 1.5 mg IV over 1 h) to treat the feline arterial thromboembolism. Within 12 h after administration of tPA, pulsation and mobility of both hind limbs were normal, without any noticeable complications. Clopidogrel was prescribed to prevent additional thrombus formation, and pimobendan, benazepril, and furosemide were prescribed for administration at home. The patient was discharged and survived 377 days.

• Journal of Chest Surgery
• /
• v.41 no.4
• /
• pp.484-488
• /
• 2008

During long-term anticoagulation treatment with using heparin in a pregnant patient with a mechanical mitral prosthesis, we observed several anticoagulation-related complications, including repeated prosthetic valve thrombosis. This was found to be caused by heparin resistance due to an anti-thrombin III deficiency. Thrombolytic therapy using urokinase or tissue plasminogen activator (tPA) was successful and safe for her as well as her baby.

• Journal of Korean Neurosurgical Society
• /
• v.63 no.4
• /
• pp.427-432
• /
• 2020

Three randomized control trials (RCTs), published in 2013, investigated efficacy of mechanical thrombectomy in large vessel occlusions and did not show better results compared to intravenous (IV) recombinant tissue-type plasminogen activator (tPA) alone. However, most clinicians treating stroke consider mechanical thrombectomy as the standard treatment rather than using IV tPA alone. This paradigm shift was based on five RCTs investigating efficacy of mechanical thrombectomy in acute ischemic stroke conducted from 2010 to 2015. They demonstrated that mechanical thrombectomy was effective and safe in acute ischemic stroke with anterior circulation occlusion when performed within 6 hours of stroke onset. There are four reasons underlying the different results observed between the trials conducted in 2013 and 2015. First, the three RCTs of 2013 used low-efficiency thrombectomy devices. Second, the three RCTs used insufficient image selection criteria. Third, following the initial presentation at the hospital, reperfusion treatment required a long time. Fourth, the three RCTs showed a low rate of successful recanalization. Time is the most important factor in the treatment of acute ischemic stroke. However, current trends utilize advanced imaging techniques, such as diffusion-weighted imaging and multi-channel computer tomographic perfusion, to facilitate the detection of core infarction, penumbra, and collateral flows. These efforts demonstrate that patient selection may overcome the barriers of time in specific cases.

• Journal of the Korean Society of Industry Convergence
• /
• v.14 no.1
• /
• pp.9-14
• /
• 2011

The excess molar enthalpies $H_m^E$ at T=298.15 K and p=101.3 kPa of ternary system {1,2-dichloropropane (1,2-DCP) + 1,3-dioxolane+ 1,4-dioxane} were predicted by using the binary contribution model of $Radojkovi{\check{c}}$ with correlated sub-binary Redlich-Kister parameters. Excess partial molar enthalpies ${\bar{H}}_i^E$ were also calculated for the binary systems {1,2-dichloropropane + 1,3-dioxolane}, {1,2-dichloropropane + 1,4-dioxane} and {1,3-dioxolane + 1,4-dioxane} using adjustable parameters of Redlich-Kister equation. By extrapolation of excess partial molar enthalpies to infinite dilution, limiting excess partial molar enthalpies ${\bar{H}}_i^{E,{\infty}}$ of each component were also obtained. The ternary excess molar enthalpies excess partial molar enthalpies of these sub-binary systems have been calculated by using our previously reported results.

• BMB Reports
• /
• v.48 no.10
• /
• pp.577-582
• /
• 2015

Cyclopia subternata is a medicinal plant commonly used in traditional medicine to relieve pain. Here, the anticoagulant effects of scolymoside, an active compound in C. subternata, were examined by monitoring activated partial thromboplastin time (aPTT), prothrombin time (PT), and the activities of thrombin and activated factor X (FXa). The effects of scolymoside on plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) expression were evaluated in tumor necrosis factor (TNF)-α-activated human endothelial cells. Treatment with scolymoside resulted in prolonged aPTT and PT and the inhibition of thrombin and FXa activities and production. In addition, scolymoside inhibited thrombin-catalyzed fibrin polymerization and platelet aggregation. Scolymoside also elicited anticoagulant effects in mice, including a significant reduction in the PAI-1 to t-PA ratio. Collectively, these findings indicate that scolymoside possesses anticoagulant activities and could be developed as a novel anticoagulant.